Why is a lyophilised peptide more stable than a solution?

Most peptide degradation routes require water as a reactant or a mobile phase. Hydrolysis, deamidation and disulfide scrambling all proceed far more slowly in a dry solid because the molecules cannot move and water is largely absent. Removing the solvent removes the mechanism.

Why does freeze-thaw damage a peptide solution?

As a solution freezes, ice forms first and solutes concentrate into the shrinking liquid fraction. That freeze concentration produces transient extremes of solute and pH at the ice interface, and the air-water interface created during the phase change promotes aggregation. The damage occurs during the transition, so it accumulates per cycle rather than with time spent frozen.

Why do dilute peptide solutions lose concentration in plastic tubes?

Peptides adsorb to polypropylene and glass surfaces. The quantity lost is roughly fixed by surface area, so it is negligible for a concentrated stock and can be a large proportion of a dilute working solution. This is a common cause of apparent potency loss where the peptide has not degraded at all.

Which residues make a peptide sequence less stable?

Asparagine and glutamine are prone to deamidation, particularly asparagine followed by glycine. Methionine, cysteine and tryptophan are prone to oxidation. Aspartate-proline bonds are acid-labile. A sequence containing these motifs has a shorter practical shelf life in solution than one that does not.

Does bacteriostatic water sterilise a peptide solution?

No. Bacteriostatic water contains benzyl alcohol, which inhibits bacterial growth. It does not sterilise a solution that is already contaminated and it does not remove endotoxin. It extends the usable window of a multi-draw vial; it does not substitute for aseptic technique.

Peptide Handling and Stability: Reconstitution, Storage and Degradation

Mechanisms

How peptides actually degrade

Five routes account for most loss of research material. Each is triggered by something you control.

Route	What happens	Triggered by	Most exposed residues
Hydrolysis	Backbone amide bonds cleave	Water, extremes of pH, heat	Asp-Pro bonds
Deamidation	Side-chain amide converts to acid, +1 Da	Water, neutral-to-alkaline pH, heat	Asn (esp. Asn-Gly), Gln
Oxidation	Sulfur and indole side chains gain oxygen	Air, light, trace metals, peroxides	Met, Cys, Trp
Aggregation	Molecules associate and drop out of solution	Interfaces, freeze-thaw, agitation, concentration	Hydrophobic sequences
Adsorption	Peptide sticks to container surfaces	Low concentration, large surface area	Any; worst when dilute

Adsorption is not degradation - the molecule is intact, just no longer in solution. It is listed here because it presents identically to potency loss and is far more common than it is diagnosed.

Physical state

Lyophilised versus in solution

01

Solid

Why the dry powder is the stable form

Nearly every route above needs water, either as a reactant or as the medium that lets molecules meet. Lyophilisation removes it. In a dry solid, molecular mobility collapses and hydrolysis and deamidation slow by orders of magnitude.

This is why a lyophilised vial tolerates ambient temperature for the days a shipment takes, while the same material in solution would not. It is also why residual water content appears on a certificate at all: leftover moisture partially re-enables the mechanisms lyophilisation was performed to shut down.

Cold storage of the sealed powder extends this further. The practical enemies of a dry vial are moisture ingress, repeated warming to room temperature causing condensation inside the vial, and light.

02

Solution

What changes the moment it is reconstituted

Adding solvent restarts every water-dependent route simultaneously. From that point the material has a finite working life measured in weeks under refrigeration, not months, and the exact figure depends on the sequence rather than on a universal rule.

Three variables dominate once in solution:

pH. Deamidation accelerates above neutral; some bonds are acid-labile below it. Most peptides are handled nearest their stability optimum in mildly acidic buffer, not in unbuffered water.
Temperature. Refrigeration slows all chemical routes. It does not stop them.
Concentration. Concentrated stocks resist adsorption losses; very dilute solutions lose a meaningful fraction to the tube wall.

03

Freezing

Why freeze-thaw is counted in cycles

Damage from freezing happens during the phase transition, not during storage at temperature. As ice forms, solutes are excluded from the crystal and concentrate into the shrinking liquid fraction - a process called freeze concentration. Local solute concentration and pH can move sharply at the ice front, and the newly created interfaces promote aggregation.

The operational consequence: aliquot before freezing. A stock split into single-use volumes experiences one cycle. The same stock thawed and refrozen ten times experiences ten, and the loss is cumulative.

Practice

Handling decisions that follow

Let the vial reach room temperature first

Opening a cold vial in humid air condenses water onto the powder. Equilibrate sealed, then open.

Add solvent down the vial wall

Directing solvent onto the cake and agitating creates the air-water interface that drives aggregation. Add slowly, swirl, do not shake.

Aliquot for single use

The cheapest stability intervention available. It converts a repeated freeze-thaw problem into a one-cycle problem.

Protect from light

Tryptophan and methionine oxidise photochemically. Amber tubes or foil cost nothing.

Use carrier protein for dilute work

Where the assay tolerates it, a carrier occupies adsorption sites that would otherwise take your peptide.

Record the reconstitution date

Solution age is a variable. An undated stock makes an anomalous result uninterpretable after the fact.

Concentration arithmetic for a given vial size and target is handled by the reconstitution calculator. Note that an accurate molar concentration depends on net peptide content, not on purity.

Continue

Related lab resources

Assay methods

What HPLC, LC-MS, net content and endotoxin each establish - and what they cannot.

Study design

Controls, replication and reporting standards that make an in-vitro result reusable.

Storage & handling summary

The short-form reference card for bench use.

Research Use Only. This page describes laboratory handling of in-vitro research compounds for qualified professionals. It is not a protocol, not medical or veterinary guidance, and contains no dosing recommendation. Nothing here is a claim of efficacy.

Handling and stability of research peptides